The evolution of drug resistance to many antimalarial drugs in the lethal strain of malaria (Plasmodium falciparum) has been a great concern over the past 50 years. Among these drugs, artemisinin has become less effective for treating malaria. Indeed, several P. falciparum variants have become resistant to this drug, as elucidated by specific mutations in the pfK13 gene. This study presents the development of a diagnostic kit for the detection of a common point mutation in the pfK13 gene of P. falciparum, namely, the C580Y point mutation. FIT-PNAs (forced-intercalation peptide nucleic acid) are DNA mimics that serve as RNA sensors that fluoresce upon hybridization to their complementary RNA. Herein, FIT-PNAs were designed to sense the C580Y single nucleotide polymorphism (SNP) and were conjugated to biotin in order to bind these molecules to streptavidin-coated plates. Initial studies with synthetic RNA were conducted to optimize the sensing system. In addition, cyclopentane-modified PNA monomers (cpPNAs) were introduced to improve FIT-PNA sensing. Lastly, total RNA was isolated from red blood cells infected with P. falciparum (WT strain - NF54-WT or mutant strain - NF54-C580Y). Streptavidin plates loaded with either FIT-PNA or cpFIT-PNA were incubated with the total RNA. A significant difference in fluorescence for mutant vs WT total RNA was found only for the cpFIT-PNA probe. In summary, this study paves the way for a simple diagnostic kit for monitoring artemisinin drug resistance that may be easily adapted to malaria endemic regions.
The space environment can affect the function of all physiological systems, including the properties of cell membranes. Our goal in this study was to explore the effect of simulated microgravity (SMG) on the cellular uptake of small molecules based on reported microgravity-induced changes in membrane properties. SMG was applied to cultured cells using a random-positioning machine for up to three hours. We assessed the cellular accumulation of compounds representing substrates of uptake and efflux transporters, and of compounds not shown to be transported by membrane carriers. Exposure to SMG led to an increase of up to 60% (p < 0.01) in the cellular uptake of efflux transporter substrates, whereas a glucose transporter substrate showed a decrease of 20% (p < 0.05). The uptake of the cathepsin activity-based probe GB123 (MW, 1198 g/mol) was also enhanced (1.3-fold, p < 0.05). Cellular emission of molecules larger than ~3000 g/mol was reduced by up to 50% in SMG (p < 0.05). Our findings suggest that short-term exposure to SMG could differentially affect drug distribution across membranes. Longer exposure to microgravity, e.g., during spaceflight, may have distinct effects on the cellular uptake of small molecules.
RNA and DNA biomarkers serve as diagnostic molecules for detecting a specific disease by a variety of methods and technologies. A common approach is based on a fluorescence readout signal generated after hybridization to a target nucleic acid sequence. One such technology is termed Forced-Intercalation Peptide Nucleic Acid (FIT-PNA). In the FIT-PNA design, one of the nucleobases of the PNA sequence is replaced by a fluorescent molecule termed as “surrogate base.” One of the more common fluorophores explored to date is the cyanine dye, Thiazole Orange (TO). In this report, we have designed TO-based FIT-PNAs that are chemically modified with a cyclopentane backbone (cpTO). In addition, we have introduced to the FIT-PNA design either a cyclopentane T (cpT) or a tetrahydrofuran T (THFT) flanking cpTO. In a model system (11-mer FIT-PNA), we observe a dramatic increase in fluorescence (with DNA or RNA complementary sequences) for both cpT-cpTO and THFT-cpTO FIT-PNAs in comparison to the unmodified counterpart (T-TO FIT-PNA). Moreover, sequence specificity for an RNA sequence with a single mismatch is dramatically improved for both cpT-cpTO and THFT-cpTO FIT-PNAs. Molecular simulations of both cpT-cpTO FIT-PNA and TO (unmodified) FIT-PNA further support the superiority of these chemically modified nucleic-acid probes, as corroborated by a greater π–π stacking of cpTO in the PNA-RNA duplex. Lastly, a cpT-cpTO FIT-PNA targeting the oncogenic long noncoding RNA ANRIL (antisense noncoding RNA in the INK4 locus) was shown to detect this RNA biomarker in ovarian cancer cells (OVCAR-8). This probe was superior to the unmodified TO-based FIT-PNA, highlighting the added value of chemically modified TO FIT-PNAs as means for obtaining highly sensitive and sequence-specific nucleic acid sensors.